UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
AMNEAL PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 32-0546926 | |
| (State of incorporation or organization) | (I.R.S. Employer Identification No.) |
Amneal Pharmaceuticals, Inc. c/o Impax Laboratories, Inc. 30831 Huntwood Ave. Hayward, CA 94544 (510)240-6000 |
| (Address of principal executive offices and zip code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered | Name of each exchange on which each class is to be registered | |
| Class A Common Stock | New York Stock Exchange | |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box ☐
Securities Act registration statement file number to which this form relates:333-221707
Securities to be registered pursuant to Section 12(g) of the Act:None
Item 1. Description of Registrant’s Securities to be Registered.
A description of the Class A Common Stock, par value $0.01 per share, of Amneal Pharmaceuticals, Inc. (the “Registrant”) is set forth under the caption “New Amneal Capital Stock” in the prospectus included in the Registrant’s Registration Statement on FormS-4 (RegistrationNo. 333-221707), initially filed with the Securities and Exchange Commission (the “Commission”) on November 21, 2017 under the Securities Act of 1933, as amended, and will be set forth in any prospectus filed in accordance with Rule 424(b) thereunder, which description is incorporated herein by reference.
Item 2. Exhibits.
None. Pursuant to the Instructions as to Exhibits with respect to Form8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on the New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Amneal Pharmaceuticals, Inc. | ||||||
Date: May 4, 2018 | By: | /s/ Bryan M. Reasons | ||||
| Bryan M. Reasons | ||||||
Chief Financial Officer | ||||||
